NEUROCRINE BIOSCIENCES INC (NBIX)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch NBIX
See up to 3 months of NBIX. The 7-day demo opens the 1M and 3M ranges and puts NBIX on your watchlist.
Start 7-day demoLatest NBIX insider trades
About NEUROCRINE BIOSCIENCES INC (NBIX)
NEUROCRINE BIOSCIENCES INC is an SEC registrant, filing under CIK 0000914475, classified as biological products (no diagnostic substances). We track it alongside the rest of the Health Care sector.
NBIX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 6,541 | $1.05M |
| Grant or award | 11 | 57,396 | |
| Option exercise | 4 | 8,072 | |
NBIX insider transactions (Form 4)
81101 Form 4 filings on record, the earliest from Oct 7, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sanjay Chandru Keswani - Officer | Grant or award | Stock Option | 35,827 | $0.00 | - | |
| Sanjay Chandru Keswani - Officer | Grant or award | Restricted Stock Unit | 6,285 | $0.00 | - | |
| David W. Boyer - Officer | Option exercise | Common Stock | 2,096 | $0.00 | - | |
| David W. Boyer - Officer | Tax withholding / forfeiture | Common Stock | 1,189 footnote F2 | $136.06 | $162K | |
| David W. Boyer - Officer | Option exercise | Restriced Stock Unit | 2,096 | $0.00 | - | |
| ||||||
| Eric Benevich - Officer | Option exercise | Common Stock | 2,294 | $0.00 | - | |
| Eric Benevich - Officer | Tax withholding / forfeiture | Common Stock | 1,292 footnote F1 | $136.06 | $176K | |
| Eric Benevich - Officer | Option exercise | Restricted Stock Unit | 2,294 | $0.00 | - | |
| ||||||
| Matt Abernethy - Officer | Option exercise | Common Stock | 2,437 | $0.00 | - | |
| Matt Abernethy - Officer | Tax withholding / forfeiture | Common Stock | 1,368 footnote F2 | $136.06 | $186K | |
| Matt Abernethy - Officer | Option exercise | Restricted Stock Unit | 2,437 | $0.00 | - | |
| ||||||
 Julie Cooke - Officer | Option exercise | Common Stock | 1,741 | $0.00 | - | |
| Julie Cooke - Officer | Tax withholding / forfeiture | Common Stock | 997 footnote F1 | $136.06 | $136K | |
| Julie Cooke - Officer | Option exercise | Restricted Stock Unit | 1,741 | $0.00 | - | |
| ||||||
| Ingrid Delaet - Officer | Option exercise | Common Stock | 801 | $0.00 | - | |
| Ingrid Delaet - Officer | Tax withholding / forfeiture | Common Stock | 475 footnote F1 | $136.06 | $65K | |
| Ingrid Delaet - Officer | Option exercise | Restriced Stock Unit | 801 | $0.00 | - | |
| ||||||
| Kyle Gano - Officer | Option exercise | Common Stock | 2,927 | $0.00 | - | |
| Kyle Gano - Officer | Tax withholding / forfeiture | Common Stock | 1,580 footnote F1 | $136.06 | $215K | |
| Kyle Gano - Officer | Option exercise | Restricted Stock Unit | 2,927 | $0.00 | - | |
| ||||||
 Kevin Charles Gorman - Director | Option exercise | Common Stock | 5,142 | $0.00 | - | |
| Kevin Charles Gorman - Director | Tax withholding / forfeiture | Common Stock | 2,845 footnote F1 | $136.06 | $387K | |
| Kevin Charles Gorman - Director | Option exercise | Restricted Stock Unit | 5,142 | $0.00 | - | |
| ||||||
| Darin Lippoldt - Officer | Option exercise | Common Stock | 2,373 | $0.00 | - | |
| Darin Lippoldt - Officer | Tax withholding / forfeiture | Common Stock | 1,335 footnote F1 | $136.06 | $182K | |
| Darin Lippoldt - Officer | Option exercise | Restricted Stock Unit | 2,373 | $0.00 | - | |
| ||||||
 Jude Onyia - Officer | Option exercise | Common Stock | 238 | $0.00 | - | |
| Jude Onyia - Officer | Tax withholding / forfeiture | Common Stock | 142 footnote F1 | $136.06 | $19K | |
| Jude Onyia - Officer | Option exercise | Restricted Stock Unit | 238 | $0.00 | - | |
| ||||||
| Kyle Gano - Officer | Option exercise | Common Stock | 34,588 | $35.99 | $1.24M | |
| Kyle Gano - Officer | Option exercise | Common Stock | 1,812 | $35.99 | $65K | |
| Kyle Gano - Officer | Open-market sale | Common Stock | 34,588 | $132.70 footnote F2 | $4.59M | |
| Kyle Gano - Officer | Open-market sale | Common Stock | 1,812 | $132.71 footnote F3 | $240K | |
| Kyle Gano - Officer | Option exercise | Non-Qualified Stock Option | 34,588 | $0.00 | - | |
| Kyle Gano - Officer | Option exercise | Incentive Stock Option | 1,812 | $0.00 | - | |
| ||||||
| Eric Benevich - Officer | Option exercise | Common Stock | 12,830 | $35.99 | $462K | |
| Eric Benevich - Officer | Option exercise | Incentive Stock Option | 12,830 | $0.00 | - | |
| Gary A. Lyons - Director | Option exercise | Common Stock | 15,000 | $47.89 | $718K | |
| Gary A. Lyons - Director | Open-market sale | Common Stock | 15,000 | $152.61 footnote F2 | $2.29M | |
| Gary A. Lyons - Director | Option exercise | Non-Qualified Stock Option | 15,000 | $0.00 | - | |
| ||||||
| Jude Onyia - Officer | Option exercise | Common Stock | 4,426 | $0.00 | - | |
| Jude Onyia - Officer | Tax withholding / forfeiture | Common Stock | 2,248 footnote F1 | $152.16 | $342K | |
| Jude Onyia - Officer | Option exercise | Restricted Stock Unit | 4,426 | $0.00 | - | |
| ||||||
| Eric Benevich - Officer | Option exercise | Common Stock | 5,970 | $35.99 | $215K | |
| Eric Benevich - Officer | Open-market sale | Common Stock | 5,970 | $151.74 footnote F3 | $906K | |
| Eric Benevich - Officer | Option exercise | Incentive Stock Option | 5,970 | $0.00 | - | |
| ||||||
| George J. Morrow - Director | Option exercise | Common Stock | 15,000 | $47.89 | $718K | |
| George J. Morrow - Director | Open-market sale | Common Stock | 15,000 | $143.37 footnote F2 | $2.15M | |
| George J. Morrow - Director | Option exercise | Non-Qualified Stock Option | 15,000 | $0.00 | - | |
| ||||||
 William H. Rastetter - Director | Option exercise | Common Stock | 18,000 | $47.89 | $862K | |
| William H. Rastetter - Director | Open-market sale | Common Stock | 18,000 | $151.82 footnote F2 | $2.73M | |
| William H. Rastetter - Director | Option exercise | Non-Qualified Stock Option | 18,000 | $0.00 | - | |
| ||||||
| Kyle Gano - Officer | Option exercise | Restricted Stock Unit | 613 | $0.00 | - | |
| Kyle Gano - Officer | Option exercise | Common Stock | 613 | $0.00 | - | |
| Kyle Gano - Officer | Open-market sale | Common Stock | 300 | $141.97 | $43K | |
| Jude Onyia - Officer | Gift | Common Stock | 1,470 | $0.00 | - | |
| Stephen A. Sherwin - Director | Gift | Common Stock | 1,000 | $0.00 | - | |
| Kevin Charles Gorman - Director | Option exercise | Common Stock | 106,322 | $35.99 | $3.83M | |
| Kevin Charles Gorman - Director | Open-market sale | Common Stock | 106,322 | $126.41 | $13.44M | |
| Kevin Charles Gorman - Director | Option exercise | Non-Qualified Stock Option | 106,322 | $0.00 | - | |
| Jude Onyia - Officer | Gift | Common Stock | 3,116 | $0.00 | - | |
| Ingrid Delaet - Officer | Option exercise | Common Stock | 457 | $79.02 | $36K | |
| Ingrid Delaet - Officer | Open-market sale | Common Stock | 457 | $135.00 | $62K | |
| Ingrid Delaet - Officer | Option exercise | Non-Qualified Stock Option | 457 | $0.00 | - | |
| Jude Onyia - Officer | Option exercise | Common Stock | 59,819 | $84.74 | $5.07M | |
| Jude Onyia - Officer | Open-market sale | Common Stock | 59,819 | $130.46 | $7.80M | |
| Jude Onyia - Officer | Option exercise | Non-Qualified Stock Option | 59,819 | $0.00 | - | |
| Jude Onyia - Officer | Option exercise | Common Stock | 20,362 | $84.74 | $1.73M | |
| Jude Onyia - Officer | Open-market sale | Common Stock | 20,362 | $130.13 | $2.65M | |
| Jude Onyia - Officer | Option exercise | Non-Qualified Stock Option | 20,362 | $0.00 | - | |
| Kevin Charles Gorman - Director | Open-market sale | Common Stock | 9,613 | $120.38 | $1.16M | |
| William H. Rastetter - Director | Option exercise | Common Stock | 2,869 | $0.00 | - | |
| William H. Rastetter - Director | Grant or award | Restricted Stock Unit | 3,318 | $0.00 | - | |
| William H. Rastetter - Director | Option exercise | Restricted Stock Unit | 2,869 | $0.00 | - | |
| Kevin Charles Gorman - Director | Grant or award | Non-Qualified Stock Option | 6,610 | $0.00 | - | |
| Christine A. Poon - Director | Option exercise | Common Stock | 1,435 | $0.00 | - | |
| Christine A. Poon - Director | Grant or award | Restricted Stock Unit | 3,318 | $0.00 | - | |
| Christine A. Poon - Director | Option exercise | Restricted Stock Unit | 1,435 | $0.00 | - | |
| Richard F. Pops - Director | Option exercise | Common Stock | 2,869 | $0.00 | - | |
| Richard F. Pops - Director | Grant or award | Restricted Stock Unit | 3,318 | $0.00 | - | |
| Richard F. Pops - Director | Option exercise | Restricted Stock Unit | 2,869 | $0.00 | - | |
See every NBIX filing on record
These pages show the latest 90 of 101 Form 4 filings on record. The 7-day demo shows all 101, and sign-up brings you back to this table.
Item 5.02
Item 9.01
Item 2.02, 9.01
Item 5.02, 5.07
Recent NBIX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| DAVID WARREN BOYER | Officer | 4,714 | $736K | View on EDGAR | |
| MATTHEW C ABERNETHY | Officer | 2,311 | $361K |
NBIX insider trading FAQ
What is the latest insider trade for NBIX?
NEUROCRINE BIOSCIENCES INC (NBIX) had 14 insider filings in the last 90 days, with the most recent on 2026-09-15. The full record for NBIX runs to 101 Form 4 filings, the earliest from 2024-10-07. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NBIX stock?
No insider purchases of NBIX were filed in the last 90 days.
How many insiders are selling NBIX stock?
4 insider sales of NBIX were filed in the last 90 days, totaling $1.05M.
Where can I see NBIX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NBIX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jude Onyia view on EDGAR
- - Darin Lippoldt view on EDGAR
- - Sanjay Chandru Keswani view on EDGAR
- - Kevin Charles Gorman view on EDGAR
- - Kyle Gano view on EDGAR
- - Ingrid Delaet view on EDGAR
- - Julie Cooke view on EDGAR
- - David W. Boyer view on EDGAR
- - Eric Benevich view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NBIX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NBIX with a 7-day demo
- NBIX on your watchlist
- Every NBIX Form 4 filing on record
- Up to 3 months of NBIX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
